Chemomab Therapeutics Ltd. (CMMB) stock
CMMBNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.53+0.13 (+9.29%)
Close on Nov 13, 2026Market cap $11.00MP/E 1.1Yield –
Chemomab Therapeutics enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Chemomab Therapeutics's enterprise value was $3.08M on Nov 11, 2026, against $4.05M a year earlier. Over the last 5 years it ranged from -$5.88M to $40.85M, with a median of $5.88M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $3.08M | – |
| 2025 | Dec 31, 2025 | -$964.32K | -104.6% |
| 2024 | Dec 31, 2024 | $20.88M | – |
| 2023 | Dec 29, 2023 | -$4.13M | -115.9% |
| 2022 | Dec 30, 2022 | $25.90M | -36.6% |
| 2021 | Dec 31, 2021 | $40.85M | -75.5% |
| 2020 | Dec 31, 2020 | $166.98M | +212.6% |
| 2019 | Dec 31, 2019 | $53.42M | – |
See a number that looks wrong?